Timothy Daley
Stock Analyst at Wells Fargo
(0.28)
# 3,337
Out of 4,667 analysts
58
Total ratings
n/a
Success rate
n/a
Average return
Main Sectors:
Stocks Rated by Timothy Daley
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| QGEN Qiagen | Initiates: Equal-Weight | $45 | $42.33 | +7.06% | 1 | Dec 19, 2023 | |
| MYGN Myriad Genetics | Initiates: Equal-Weight | $20 | $15.12 | +32.28% | 1 | Dec 19, 2023 | |
| RVTY Revvity | Initiates: Equal-Weight | $95 | $111.11 | -14.50% | 1 | Dec 19, 2023 | |
| BRKR Bruker | Initiates: Equal-Weight | $72 | $56.22 | +28.07% | 1 | Dec 19, 2023 | |
| A Agilent Technologies | Maintains: Overweight | $160 → $145 | $132.06 | +9.80% | 5 | Nov 22, 2023 | |
| MTD Mettler-Toledo International | Maintains: Overweight | $1,520 → $1,300 | $1,196.82 | +8.62% | 5 | Nov 13, 2023 | |
| WAT Waters | Maintains: Equal-Weight | $305 → $285 | $368.50 | -22.66% | 5 | Nov 8, 2023 | |
| DHR Danaher | Maintains: Overweight | $285 → $247 | $235.05 | +5.08% | 3 | Oct 3, 2023 | |
| CRL Charles River Laboratories International | Maintains: Overweight | $280 → $275 | $194.19 | +41.61% | 4 | Sep 22, 2023 | |
| LH Labcorp Holdings | Maintains: Overweight | $290 → $270 | $240.17 | +12.42% | 3 | Aug 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $22 → $28 | $14.58 | +92.04% | 2 | Aug 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $30 → $35 | $19.62 | +78.39% | 6 | Jul 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $505 → $520 | $516.10 | +0.76% | 3 | Jul 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $9 | $3.41 | +163.93% | 1 | Jul 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $185 | $141.76 | +30.50% | 1 | Jul 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $80 → $85 | $78.72 | +7.98% | 3 | May 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $235 → $220 | $197.60 | +11.34% | 2 | May 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $245 → $220 | $212.76 | +3.40% | 2 | May 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $25 → $28 | $20.36 | +37.52% | 4 | Feb 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $135 → $140 | $163.89 | -14.58% | 2 | Feb 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Equal-Weight | $90 | $71.05 | +26.67% | 3 | Jan 10, 2023 |
Qiagen
Dec 19, 2023
Initiates: Equal-Weight
Price Target: $45
Current: $42.33
Upside: +7.06%
Myriad Genetics
Dec 19, 2023
Initiates: Equal-Weight
Price Target: $20
Current: $15.12
Upside: +32.28%
Revvity
Dec 19, 2023
Initiates: Equal-Weight
Price Target: $95
Current: $111.11
Upside: -14.50%
Bruker
Dec 19, 2023
Initiates: Equal-Weight
Price Target: $72
Current: $56.22
Upside: +28.07%
Agilent Technologies
Nov 22, 2023
Maintains: Overweight
Price Target: $160 → $145
Current: $132.06
Upside: +9.80%
Mettler-Toledo International
Nov 13, 2023
Maintains: Overweight
Price Target: $1,520 → $1,300
Current: $1,196.82
Upside: +8.62%
Waters
Nov 8, 2023
Maintains: Equal-Weight
Price Target: $305 → $285
Current: $368.50
Upside: -22.66%
Danaher
Oct 3, 2023
Maintains: Overweight
Price Target: $285 → $247
Current: $235.05
Upside: +5.08%
Charles River Laboratories International
Sep 22, 2023
Maintains: Overweight
Price Target: $280 → $275
Current: $194.19
Upside: +41.61%
Labcorp Holdings
Aug 14, 2023
Maintains: Overweight
Price Target: $290 → $270
Current: $240.17
Upside: +12.42%
Aug 14, 2023
Maintains: Overweight
Price Target: $22 → $28
Current: $14.58
Upside: +92.04%
Jul 31, 2023
Maintains: Overweight
Price Target: $30 → $35
Current: $19.62
Upside: +78.39%
Jul 28, 2023
Maintains: Underweight
Price Target: $505 → $520
Current: $516.10
Upside: +0.76%
Jul 20, 2023
Initiates: Overweight
Price Target: $9
Current: $3.41
Upside: +163.93%
Jul 20, 2023
Initiates: Overweight
Price Target: $185
Current: $141.76
Upside: +30.50%
May 2, 2023
Maintains: Equal-Weight
Price Target: $80 → $85
Current: $78.72
Upside: +7.98%
May 1, 2023
Maintains: Equal-Weight
Price Target: $235 → $220
Current: $197.60
Upside: +11.34%
May 1, 2023
Maintains: Equal-Weight
Price Target: $245 → $220
Current: $212.76
Upside: +3.40%
Feb 8, 2023
Maintains: Overweight
Price Target: $25 → $28
Current: $20.36
Upside: +37.52%
Feb 3, 2023
Maintains: Equal-Weight
Price Target: $135 → $140
Current: $163.89
Upside: -14.58%
Jan 10, 2023
Upgrades: Equal-Weight
Price Target: $90
Current: $71.05
Upside: +26.67%